Gujarat kidney and super speciality limited IPO Overview
Gujarat kidney and super speciality limited IPO is a Mainboard public issue offered through a Book Building issue with a total issue size of ₹250.80 Cr. The IPO price band is set at ₹108 to ₹114 per share, and retail investors can apply with a minimum investment of ₹14,592 as per IPO guidelines.
The Gujarat kidney and super speciality limited IPO opens on 22 Dec 2025 and closes on 24 Dec 2025. The IPO allotment is expected to be finalized on 26 Dec 2025, and the equity shares are proposed to be listed on BSE,NSE on 30 Dec 2025.
Investors can refer to the Gujarat kidney and super speciality limited IPO RHP-DRHP for detailed information. The issue is managed by Nirbhay Capital Services Pvt.Ltd as the book running lead manager, while MUFG Intime India Private Limited (Link Intime) is the registrar to the IPO. Before investing, market participants often review IPO details, valuation, PE ratio, financials, and risk factors.
About gujarat kidney and super speciality limited
The company operates seven multispeciality hospitals and four pharmacies with a total bed capacity of 490 beds, an approved capacity of 455 beds, and an operational capacity of 340 beds.
The company's hospitals include Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), M/s. Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), and Ashwini Medical Centre (Anand). The company also operates Ashwini Medical Store (Anand).